AI
| Followers | 843 |
| Posts | 122799 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Thursday, September 04, 2008 5:24:43 PM
IDIX Drug Portfolio
What’s changed relative to the prior
version of this chart six months ago?
Three things:
1. IDX184 for HCV has moved from preclinical into phase-1.
2. The HCV protease inhibitors now have names (IDX136, IDX316) and have moved closer to phase-1.
3. The HCV non-nucleoside polymerase inhibitor now has a name (IDX375) and has moved closer to phase-1.
What’s changed relative to the prior
version of this chart six months ago?
Three things:
1. IDX184 for HCV has moved from preclinical into phase-1.
2. The HCV protease inhibitors now have names (IDX136, IDX316) and have moved closer to phase-1.
3. The HCV non-nucleoside polymerase inhibitor now has a name (IDX375) and has moved closer to phase-1.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
